INTRODUCTION: Recent evidence implicates a cholinergic anti-inflammatory pathway. Because vagus nerve activity mediates some heart rate variability (HRV), this qualitative review examines the literature concerning circulating cytokines and HRV in cardiovascular function in humans. This qualitative review examines the literature concerning circulating cytokines and HRV in cardiovascular function in humans. METHODS: Thirteen studies on HRV, inflammation, and cardiovascular function were located by electronic library search and descriptively reviewed. RESULTS: The relationship between HRV and inflammation was studied in healthy controls, patients with acute or stable coronary heart disease (CHD), patients with metabolic syndrome or impaired glucose tolerance and patients with kidney failure. Investigations focused mainly on Interleukin-6 (IL-6) and C-reactive peptide (CRP). The majority of reviewed studies reported that parasympathetic nervous system tone as inferred from heart rate variability is inversely related to inflammatory markers (r values between -0.2 and -0.4). The relationships with inflammatory markers were similar whether derived from ECG signals as short as 5-30min or from 24-h ECG readings for HRV analyses. While inflammatory markers appear to be related to HRV, it is a mistake to assume that the traditional "vagal measures" of HRV (such as high frequency heart rate variability) are the driving factors. Indeed, low frequency heart rate variability, a complex measure reflecting both parasympathetic and sympathetic activity, is the more commonly associated measure linked to inflammatory markers. DISCUSSION: Heart rate variability is inversely correlated with inflammatory markers in healthy individuals as well as in those with cardiovascular diseases.
INTRODUCTION: Recent evidence implicates a cholinergic anti-inflammatory pathway. Because vagus nerve activity mediates some heart rate variability (HRV), this qualitative review examines the literature concerning circulating cytokines and HRV in cardiovascular function in humans. This qualitative review examines the literature concerning circulating cytokines and HRV in cardiovascular function in humans. METHODS: Thirteen studies on HRV, inflammation, and cardiovascular function were located by electronic library search and descriptively reviewed. RESULTS: The relationship between HRV and inflammation was studied in healthy controls, patients with acute or stable coronary heart disease (CHD), patients with metabolic syndrome or impaired glucose tolerance and patients with kidney failure. Investigations focused mainly on Interleukin-6 (IL-6) and C-reactive peptide (CRP). The majority of reviewed studies reported that parasympathetic nervous system tone as inferred from heart rate variability is inversely related to inflammatory markers (r values between -0.2 and -0.4). The relationships with inflammatory markers were similar whether derived from ECG signals as short as 5-30min or from 24-h ECG readings for HRV analyses. While inflammatory markers appear to be related to HRV, it is a mistake to assume that the traditional "vagal measures" of HRV (such as high frequency heart rate variability) are the driving factors. Indeed, low frequency heart rate variability, a complex measure reflecting both parasympathetic and sympathetic activity, is the more commonly associated measure linked to inflammatory markers. DISCUSSION: Heart rate variability is inversely correlated with inflammatory markers in healthy individuals as well as in those with cardiovascular diseases.
Authors: Jari M Tapanainen; Poul Erik Bloch Thomsen; Lars Køber; Christian Torp-Pedersen; Timo H Mäkikallio; Aino-Maija Still; Kai S Lindgren; Heikki V Huikuri Journal: Am J Cardiol Date: 2002-08-15 Impact factor: 2.778
Authors: S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts Journal: N Engl J Med Date: 1997-10-09 Impact factor: 91.245
Authors: Sae Young Jae; Kevin S Heffernan; Soo-Hyun Park; Sun-Hae Jung; Eun Sun Yoon; Euy Jin Kim; Eui Soo Ahn; Bo Fernhall Journal: Clin Auton Res Date: 2010-05-01 Impact factor: 4.435
Authors: Lucien D Durosier; Christophe L Herry; Marina Cortes; Mingju Cao; Patrick Burns; André Desrochers; Gilles Fecteau; Andrew J E Seely; Martin G Frasch Journal: Physiol Meas Date: 2015-08-19 Impact factor: 2.833
Authors: Lari C Young; Mollie P Roediger; Greg Grandits; Jason Baker; Charurut Somboonwit; Ian Williams; Jens D Lundgren; James D Neaton; Elsayed Z Soliman Journal: Biomark Med Date: 2014 Impact factor: 2.851